Terminated NA INTERVENTIONAL 2-arm NCT05934903

Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus

Sponsor: Yale University

Conditions Refractory Status Epilepticus Status Epilepticus

Interventions Transcranial Direct Current Stimulation

Updated 6 times since 2023 Last updated: Mar 31, 2025 Started: Aug 31, 2023 Primary completion: Mar 31, 2025 Completion: Mar 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Unable to meet adequate enrolment numbers for feasibility.

Other terminated trials from Yale University

See all terminations from Yale University

Other Refractory Status Epilepticus trials with similar outcome

NCT05684978 · Phase PHASE4 · Oct 2025

Browse all Refractory Status Epilepticus trials

This NA trial investigates Refractory Status Epilepticus and Status Epilepticus and is currently terminated or withdrawn. Yale University leads this study, which shows 6 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

May 2025 — Present [monthly]

Terminated NA

Status: Recruiting → Terminated
Sep 2024 — May 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2024 — Jul 2024 [monthly]

Recruiting NA
Nov 2023 — May 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Aug 2023 — Nov 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States